Avalon GloboCare (ALBT) EBIT (2015 - 2026)

Avalon GloboCare's EBIT history runs 12 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

• On a quarterly basis, EBIT fell 52.41% year-over-year to -$2.7 million in Q1 2026; TTM through Mar 2026 was -$8.5 million, a 47.07% decrease from a year earlier, with the FY2025 full-year figure at -$7.6 million, down 56.81% from the prior year.
• EBIT retreated to -$2.7 million in Q1 2026 per ALBT's latest filing, from -$1.8 million in the prior quarter.
• Across five years, EBIT topped out at $116846.0 in Q1 2023 and bottomed at -$10.5 million in Q4 2022.
• The 5-year median for EBIT is -$1.8 million (2025), against an average of -$2.7 million.
• Across the five-year window, EBIT jumped 105.49% in 2023 and slumped 821.52% in 2024, its largest moves.
• Year by year, EBIT stood at -$10.5 million in 2022, then advanced by 6.78% to -$9.8 million in 2023, then surged by 87.5% to -$1.2 million in 2024, then tumbled by 48.74% to -$1.8 million in 2025, then sank by 49.48% to -$2.7 million in 2026.
• Per Business Quant, the three latest ALBT EBIT figures stand at -$2.7 million (Q1 2026), -$1.8 million (Q4 2025), and -$76193.0 (Q3 2025).